Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||
| DOI | 10.1128/MBIO.03669-24 | ||
| Año | 2025 | ||
| Tipo |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Methicillin-resistant Staphylococcus aureus (MRSA) is a major public health menace. The global spread of MRSA is characterized by successive waves of epidemic clones dominating specific geographical regions. The acquisition of genes encoding resistance to heavy metals (HMRGs) is thought to be a key feature in the geographic divergence of MRSA. However, the cause-effect relationship between the presence of HMRGs and the divergence of MRSA clones remains to be clarified. In this study, we assessed the role that HMRGs may have played in the evolutionary divergence of the MRSA ST5-SCCmecI lineage in Latin America. We conducted a genomic characterization of 113 MRSA clinical isolates from six Latin American healthcare centers, including 53 isolates collected from two cities in Chile (Santiago and Concepción). We found a plasmid (pSCL4752) harboring arsenic, cadmium, and mercury resistance genes in 65% (n = 71) of the ST5-SCCmecI isolates. We also observed a geographic divergence associated with the presence of pSCL4752 in Chilean isolates, with a higher frequency in isolates from Concepción (88%) compared to Santiago (29%). Interestingly, a molecular clock analysis revealed that this divergence occurred in the aftermath of an 8.8 Mw earthquake and tsunami that struck the Concepción area in 2010. Moreover, our results demonstrate that the carriage of pSCL4752 can be beneficial or detrimental for ST5-SCCmecI isolates, depending on the environmental availability of these heavy metals. Our results suggest that the divergence of the ST5-SCCmecI MRSA lineage in Latin America could have been fostered by environmental disasters and influenced by the presence/absence of HMRGs harbored in a plasmid.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Martínez, Jose R.W. | - |
Universidad del Desarrollo - Chile
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile |
| 2 | Alcalde-Rico, Manuel | - |
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile
Pontificia Universidad Católica de Valparaíso - Chile Hospital Universitario Virgen Macarena - España |
| 3 | Jara-Videla, Estefanía | - |
Universidad del Desarrollo - Chile
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile |
| 4 | Reyes, Jinnethe | - |
Universidad El Bosque - Colombia
|
| 5 | Carvajal, Lina P. | Mujer |
Universidad El Bosque - Colombia
|
| 6 | RINCON-NUNEZ, SANDRA LILIANA | Mujer |
Universidad El Bosque - Colombia
|
| 7 | Rios, Rafael | Hombre |
Universidad El Bosque - Colombia
|
| 8 | Diaz, Lorena | - |
Universidad del Desarrollo - Chile
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile |
| 9 | Quesille-Villalobos, Ana | - |
Universidad del Desarrollo - Chile
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile |
| 10 | Riquelme-Neira, Roberto | - |
Universidad del Desarrollo - Chile
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile Universidad de Las Américas Chile - Chile |
| 11 | Rivas, Lina | - |
Universidad del Desarrollo - Chile
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile |
| 12 | Moustafa, Ahmed M. | Hombre |
The Children's Hospital of Philadelphia - Estados Unidos
University of Pennsylvania Perelman School of Medicine - Estados Unidos |
| 13 | Hanson, Blake M. | Hombre |
UTHealth Houston School of Public Health - Estados Unidos
|
| 14 | Undurraga, Eduardo A. | - |
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile
Pontificia Universidad Católica de Chile - Chile Centro de Investigación para la Gestión Integrada del Riesgo de Desastres (CIGIDEN) - Chile Canadian Institute for Advanced Research - Canadá |
| 15 | Olivares-Pacheco, Jorge | - |
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile
Pontificia Universidad Católica de Valparaíso - Chile |
| 16 | García, Patricia | - |
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile
Escuela de Medicina - Chile |
| 17 | Araos, Rafael | - |
Universidad del Desarrollo - Chile
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile |
| 18 | Planet, Paul J. | Hombre |
The Children's Hospital of Philadelphia - Estados Unidos
University of Pennsylvania Perelman School of Medicine - Estados Unidos American Museum of Natural History - Estados Unidos |
| 19 | Arias, Cesar A. | Hombre |
Houston Methodist Hospital - Estados Unidos
Houston Methodist - Estados Unidos Weill Cornell Medicine - Estados Unidos |
| 20 | Munita, Jose M. | - |
Universidad del Desarrollo - Chile
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile |
| Fuente |
|---|
| FONDEQUIP |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| National Institutes of Health |
| National Institute of Allergy and Infectious Diseases |
| AstraZeneca |
| Universidad El Bosque |
| ANID Fondecyt |
| Agencia Nacional de Investigación y Desarrollo |
| K24AI121296 César A. Arias National Institute of Allergy and Infectious Diseases P01AI152999-01 César A. Arias Agencia Nacional de Investigación y Desarrollo FONDECYT |
| Molecular Genetics and Antimicrobial Resistance Unit |
| Agradecimiento |
|---|
| We gratefully acknowledge the Molecular Genetics and Antimicrobial Resistance Unit, from Universidad El Bosque, Bogota, Colombia, for the isolates included in this study. This research was funded by the following research grants: FONDECYT 1171805, BECAS/DOCTORADO NACIONAL 21110001 (J.R.W.M.), ANID FONDECYT POSTDOCTORADO No. 3201034 (R.R.-N.), FONDECYT POSTDOCTORADO 3220577 (A.Q.-V.), and FONDECYT 1211947. The computational infrastructure was provided by FONDEQUIP EQM150093. C.A.A. was supported by NIH/NIAID grants K24AI121296, R01AI134637, R01AI148342-01, and P01AI152999-01. Rafael Araos participated in a COVID-19 international advisory board organized by AstraZeneca in March 2022. The other authors declare no competing interests. Agencia Nacional de Investigaci\u00F3n y Desarrollo FONDECYT 1171805,FONDECYT 1211947,FONDEQUIP EQM150093 Jose M. Munita Common Fund R01AI134637,R01AI148342-01,K24AI121296 C\u00E9sar A. Arias National Institute of Allergy and Infectious Diseases P01AI152999-01 C\u00E9sar A. Arias Agencia Nacional de Investigaci\u00F3n y Desarrollo FONDECYT POSTDOCTORADO 3201034 Roberto Riquelme-Neira Agencia Nacional de Investigaci\u00F3n y Desarrollo FONDECYT POSTDOCTORADO 3220577 Ana Quesille-Villalobos Agencia Nacional de Investigaci\u00F3n y Desarrollo BECAS/DOCTORADO NACIONAL 21110001 Jose R. W. Mart\u00EDnez |